22157.jpg
Levofloxacin Market Forecast Reveals Rapid Growth in Asia-Pacific Region and Advancements in Targeted Therapies
29 janv. 2024 11h15 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Levofloxacin Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global attention turns to the recent...
22157.jpg
Global Pseudomonas Aeruginosa Infection Treatment Market Research Report 2024
29 janv. 2024 09h35 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. As the healthcare...
22157.jpg
Global Hepatitis Therapeutics Market On The Rise: Projected Growth of USD 18.8 Billion By 2030 with North America Leading the Way
24 janv. 2024 06h12 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Hepatitis Therapeutics Market 2030 by Hepatitis Type, Drug Class, Drug Type, End-user and Distribution Channel and Region - Partner &...
22157.jpg
Global Hepatitis B Tests Market Forecasts to 2033: In-Depth Analysis of Segments, Regulatory Landscape, and Emerging Trends
23 janv. 2024 11h23 HE | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
Global Pseudomonas Aeruginosa Infection Treatment Market
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging
22 janv. 2024 05h18 HE | Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas...
22157.jpg
Global COVID-19 Nucleic Acid Amplification Tests (NAATs) Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape
16 janv. 2024 13h08 HE | Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and...
22157.jpg
United States LOTEMAX SM (Loteprednol Etabonate Ophthalmic Gel) Drug Insights and Market Forecasts Report, 2019-2022 and 2023-2032
14 déc. 2023 10h38 HE | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "LOTEMAX SM Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
REBYOTA (RBX2660) Drug Insight and Market Forecasts, 2032: Focus on United States, Germany, France, Italy, Spain United Kingdom, and Japan
14 déc. 2023 10h33 HE | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "REBYOTA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
SER-109: A Potential First-in-Class Investigational Oral Microbiome Therapeutic Designed to Reduce the Recurrence of CDI - Drug Insights and Market Forecasts to 2032
13 déc. 2023 04h13 HE | Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "SER-109 Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
Chronic Hepatitis B Market Forecast to 2032: Significant Growth Expected with USD 1,500 Million in US 7MM and Emerging Therapies Uptake
11 déc. 2023 08h38 HE | Research and Markets
Dublin, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The "Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Global...